120 related articles for article (PubMed ID: 23597140)
1. Asymptomatic bulky Hodgkin lymphoma over 8 years with elevated alpha fetoprotein.
Au WY; Wong SH; Suen WS; Ma ES; Chui WH
Leuk Lymphoma; 2014 Jan; 55(1):207-8. PubMed ID: 23597140
[No Abstract] [Full Text] [Related]
2. Guidelines for the first line management of classical Hodgkin lymphoma.
Follows GA; Ardeshna KM; Barrington SF; Culligan DJ; Hoskin PJ; Linch D; Sadullah S; Williams MV; Wimperis JZ;
Br J Haematol; 2014 Jul; 166(1):34-49. PubMed ID: 24712411
[No Abstract] [Full Text] [Related]
3. Change of initial staging at early remission evaluation with FDG-PET/CT in Hodgkin lymphoma: a report of two cases.
Molin D; Hagberg H; Suurküla M; Aström G
Acta Oncol; 2010 May; 49(4):526-8. PubMed ID: 20397779
[No Abstract] [Full Text] [Related]
4. A strange case of phyllodes tumor detected using (18)F-FDG PET/CT in an adolescent patient affected by Hodgkin lymphoma: a possible pitfall.
Cucinotta M; Quartuccio N; Coppolino P; La Delfa V; Bianchi M; Fagioli F; Cistaro A
Clin Lymphoma Myeloma Leuk; 2014 Dec; 14(6):e201-5. PubMed ID: 25240649
[No Abstract] [Full Text] [Related]
5. Pulmonary lymphocyte-rich classical Hodgkin lymphoma with early response to ABVD therapy.
Honda A; Nakamura F; Nannya Y; Shintani Y; Fukayama M; Ichikawa M; Kurokawa M
Ann Hematol; 2014 Jun; 93(6):1073-4. PubMed ID: 24173088
[No Abstract] [Full Text] [Related]
6. Serum VEGF as a significant marker of treatment response in hodgkin lymphoma.
Ben Arush MW; Ben Barak A; Maurice S; Livne E
Pediatr Hematol Oncol; 2007 Mar; 24(2):111-5. PubMed ID: 17454776
[TBL] [Abstract][Full Text] [Related]
7. Assessment of tumor size reduction improves outcome prediction of positron emission tomography/computed tomography after chemotherapy in advanced-stage Hodgkin lymphoma.
Kobe C; Kuhnert G; Kahraman D; Haverkamp H; Eich HT; Franke M; Persigehl T; Klutmann S; Amthauer H; Bockisch A; Kluge R; Wolf HH; Maintz D; Fuchs M; Borchmann P; Diehl V; Drzezga A; Engert A; Dietlein M
J Clin Oncol; 2014 Jun; 32(17):1776-81. PubMed ID: 24799482
[TBL] [Abstract][Full Text] [Related]
8. Treatment of Hodgkin lymphoma: a 50-year perspective.
Canellos GP; Rosenberg SA; Friedberg JW; Lister TA; Devita VT
J Clin Oncol; 2014 Jan; 32(3):163-8. PubMed ID: 24441526
[No Abstract] [Full Text] [Related]
9. Diffusion-weighted MRI compared to FDG PET-CT in the staging and response assessment of Hodgkin lymphoma.
Marzolini M; Wong WL; Ardeshna K; Padhani A; D'Sa S
Br J Haematol; 2012 Mar; 156(5):557. PubMed ID: 22150023
[No Abstract] [Full Text] [Related]
10. Definition of bulky disease in early stage Hodgkin lymphoma in computed tomography era: prognostic significance of measurements in the coronal and transverse planes.
Kumar A; Burger IA; Zhang Z; Drill EN; Migliacci JC; Ng A; LaCasce A; Wall D; Witzig TE; Ristow K; Yahalom J; Moskowitz CH; Zelenetz AD
Haematologica; 2016 Oct; 101(10):1237-1243. PubMed ID: 27390360
[TBL] [Abstract][Full Text] [Related]
11. Evidence of a graft-versus-Hodgkin lymphoma effect in the setting of extensive bone marrow involvement.
Anderlini P; Swanston N; Rashid A; Bueso-Ramos C; Macapinlac HA; Champlin RE
Biol Blood Marrow Transplant; 2008 Apr; 14(4):478-80. PubMed ID: 18342791
[No Abstract] [Full Text] [Related]
12. PET2 -driven de-escalation therapy in 64 high-risk Hodgkin Lymphoma patients treated with escalated BEACOPP.
Deau B; Franchi P; Briere J; Ohnona J; Tamburini J; Thieblemont C; Brice P
Br J Haematol; 2015 Jul; 170(2):278-81. PubMed ID: 25580881
[No Abstract] [Full Text] [Related]
13. Elevated alpha-fetoprotein secondary to Hodgkin's lymphoma.
Hurley LJ; Burke CR; Shetty SK; Sakr OE; Previte SR; Libertino JA
Urology; 1996 Dec; 48(6):936-8. PubMed ID: 8973683
[TBL] [Abstract][Full Text] [Related]
14. A case of Stage IA classical Hodgkin lymphoma with FDG-avid tonsils.
Vatopoulou T; Lawson C; Pocock C
Br J Haematol; 2016 Apr; 173(2):178. PubMed ID: 26872151
[No Abstract] [Full Text] [Related]
15. Failure of fluorodeoxyglucose positron emission tomography to detect the high-grade transformation of nodular lymphocyte predominant Hodgkin's lymphoma.
Puyade M; Yacoub M; Tomowiak C; Diviné M; Perdrisot R; Guilhot F; Delwail V
Acta Haematol; 2013; 129(4):229-31. PubMed ID: 23328622
[No Abstract] [Full Text] [Related]
16. Fine-Tuning the Treatment of Hodgkin's Lymphoma.
Bartlett NL
N Engl J Med; 2016 Jun; 374(25):2490-2. PubMed ID: 27332908
[No Abstract] [Full Text] [Related]
17. Primary bone marrow Hodgkin lymphoma in an HIV-negative patient.
Dholaria B; Alapat D; Arnaoutakis K
Int J Hematol; 2014 Apr; 99(4):503-7. PubMed ID: 24532438
[TBL] [Abstract][Full Text] [Related]
18. An incidentally detected paraaortic mass diagnosed as bulky disease.
Cağdaş M; Velibey Y; Calik AN; Satilmiş S
Turk Kardiyol Dern Ars; 2012 Mar; 40(2):197. PubMed ID: 22710596
[No Abstract] [Full Text] [Related]
19. Early stage, bulky Hodgkin lymphoma patients have a favorable outcome when treated with or without consolidative radiotherapy: potential role of PET scan in treatment planning.
Nguyen VT; Pophali PA; Tsai JP; Jagadeesh D; Dean RM; Pohlman B; Morgan DS; Greer JP; Smith MR; Hill BT; Reddy NM
Br J Haematol; 2017 Nov; 179(4):674-676. PubMed ID: 27409578
[No Abstract] [Full Text] [Related]
20. False-Positive Positron Emission Tomography After Combined-Modality Induction Therapy in a Patient With Newly Diagnosed Early-Stage Bulky Classic Hodgkin Lymphoma.
Cramer FM; Chuang HH; Miranda RN; Lee HJ
J Oncol Pract; 2019 Sep; 15(9):499-501. PubMed ID: 31310574
[No Abstract] [Full Text] [Related]
[Next] [New Search]
